Market Overview

UBS: Buy The Weakness In Conagra Brands

UBS: Buy The Weakness In Conagra Brands

Conagra Brands Inc (NYSE: CAG), the parent company of food brands like Hebrew National hot dogs and Pam cooking spray, have lost around 10 percent in the past two weeks, and investors should consider buying the dip, according to UBS.

The Analyst

UBS' Steven Strycula upgraded Conagra Brands from Neutral to Buy with a price target lifted from $38 to $40. 

The Thesis

Conagra's stock weakness could be attributed to multiple concerns that are "overstated," Strycula said in the upgrade note. (See his track record here.) 

They are:

  • A slowdown in total sales, including the contribution from the soon-to-be-finalized Pinnacle acquisition.
  • The size of the equity offering to finance the transaction.

The Pinnacle acquisition should close by the end of October, and synergies from the deal should come in ahead of Street estimates, the analyst said. Favorable expectations for the transaction should help Conagra's stock re-rate from its current valuation discount to its peers to a premium valuation, he said. 

Price Action

Conagra Brands shares were up 2.83 percent at $34.54 at the time of publication Monday. 

Related Links:

Some Perspective On A Possible Pinnacle Foods Buyout

4 Reasons Analysts See Upside In Conagra Shares

Latest Ratings for CAG

Jun 2019MaintainsBuy
Jun 2019Initiates Coverage OnOutperform
May 2019ReinstatesEqual-Weight

View More Analyst Ratings for CAG
View the Latest Analyst Ratings

Posted-In: food Steven Strycula UBSAnalyst Color Upgrades Price Target Analyst Ratings Best of Benzinga


Related Articles (CAG)

View Comments and Join the Discussion!

Latest Ratings

GTYHInitiates Coverage On7.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Mid-Morning Market Update: Markets Edge Higher; ENSCO And Rowan Agree To Merge

Altimmune Shares Volatile After Presentation of Positive Flu Vaccine Data at IDWeek